Danaparoid

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Danaparoid sodium

Definition
This section has been translated automatically.

Danaparoid sodium (mixture of low molecular weight sulphated glycosaminoglycans - dermatan, chondrotin and heparan sulphate - from animal intestinal mucosa). Selective factor Xa inhibitor. Danaparoid shows no cross-reaction to heparin-associated antibodies and is therefore the drug of choice in patients with HIT-2.

Half-life
This section has been translated automatically.

24.5 hours.

Indication
This section has been translated automatically.

Thrombosis prophylaxis in patients with heparin-associated thrombopenia and after allergic reactions to systemic heparins (see heparin-induced thrombocytopenia).

Dosage and method of use
This section has been translated automatically.

Prophylaxis of deep vein thrombosis: 2 times/day 750 IU/day s.c; for the treatment of HIT-2: intial 2500 IU. i.v. At KG < 55kg 1250 IU., at > 90 kg 3750 IU., then 400 IU/h over 3 hours. Maintenance dose: 150-200 IU/h. Contraindication in renal and hepatic failure.

Remember! No i.m. application!

Preparations
This section has been translated automatically.

Orgaran

Literature
This section has been translated automatically.

  1. Greinacher A et al (2003) Heparin-induced thrombocytopenia. Dtsch Ärztebl 100: 2220-2229
  2. HA Neumann (2014) The coagulation system. ABW-Scientific Publisher GmbH Berlin

Authors

Last updated on: 29.10.2020